1. Guidance for Industry: Q3B (R2) Impurities in New Drug Products (2006) US Food Drug Administration, Rockville. https://www.fda.gov. Accessed 13 Dec 2022
2. Product Properties Test Guidelines OPPTS 830.1550 Product Identity and Composition (1996) United States Environmental Protection Agency, Washington. https://www.epa.gov. Accessed 23 Jan 2023
3. Görög S (2018) Critical review of reports on impurity and degradation product profiling in the last decade. Trends Anal Chem 101:2–16
4. Safety Testing of Drug Metabolites: Guidance for Industry (2020) US Food Drug Administration, Rockville. https://www.fda.gov. Accessed 13 Dec 2022
5. Health Effects Test Guidelines OPPTS 870.7485 Metabolism and Pharmacokinetics (1998) United States Environmental Protection Agency, Washington. https://www.epa.gov. Accessed 23 Jan 2023